Nipple sparing mastectomy
ProcedureProphylactic open NSM procedures
NCT Number: NCT04447339
This is retrospective, multicenter chart review is to evaluate the complication rates of prophylactic open NSM procedures through 42 days postoperatively
This study is active but is not currently recruiting participants.
Notify Me18 year and older
Female
Observational
NorthShore University Health System, Evanston, Illinois, United States
This is retrospective, multicenter chart review is to evaluate the complication rates of prophylactic open NSM procedures through 42 days postoperatively
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
All female patients that have undergone open prophylactic NSM cases performed between January 1, 2018 through 42 days prior to IRB approval
Exclusion criteria
-
Prophylactic open NSM procedures
Time frame: IntraOperative period through 42 days postoperatively
To assess the number of open prophylactic nipple sparing mastectomy complications compared to the number of procedures
Time frame: IntraOperative period through 42 days postoperatively
Ability to completely excise memory gland tissue and preserve Nipple Areola Complex
Intuitive Surgical
Industry
A Retrospective, Multicenter Study of Open Nipple Sparing Mastectomy (NSM)
Acronym: NSM Open
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03892980
Nipple Sparing Mastectomy
Jacksonville, Florida, United States
View Trial DetailsNCT06073808
Benign Breast Condition, Gender Affirmation Surgery
Palo Alto, California, United States
View Trial DetailsNCT05917834
Breast Cancer, Breast Diseases
Seoul, South Korea
View Trial Details